A carregar...
Rosiglitazone ameliorates tissue plasminogen activator‐induced brain hemorrhage after stroke
OBJECTIVE: Delayed thrombolytic therapy with recombinant tissue plasminogen activator (tPA) may exacerbate blood‐brain barrier (BBB) breakdown after ischemic stroke and lead to catastrophic hemorrhagic transformation (HT). Rosiglitazone(RSG), a widely used antidiabetic drug that activates peroxisome...
Na minha lista:
| Publicado no: | CNS Neurosci Ther |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6887660/ https://ncbi.nlm.nih.gov/pubmed/31756041 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13260 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|